Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro

被引:87
作者
Yu, Jun [1 ,2 ]
Zhang, Sui [2 ,3 ]
Chu, Eagle S. H. [2 ]
Go, Minnie Y. Y. [2 ]
Lau, Rebecca H. Y. [2 ]
Zhao, Junhong [2 ]
Wu, Chung-Wah [2 ]
Tong, Lixin [3 ]
Zhao, Jingmin [4 ]
Poon, Terence C. W. [2 ]
Sung, Joseph J. Y. [2 ]
机构
[1] Chinese Univ Hong Kong, Dept Med & Therapeut, Inst Digest Dis, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Med & Therapeut, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China
[3] Hebei Med Univ, Affiliated Hosp 1, Ctr Liver Dis, Shijiazhuang, Peoples R China
[4] 302 Mil Hosp China, Dept Pathol, Beijing, Peoples R China
关键词
PPAR gamma; Gene modulation; Genetic deficiency mouse model; Nutritional steatohepatins; Fibrosis; Hepatic stellat cell; NONALCOHOLIC STEATOHEPATITIS; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; LIVER FIBROSIS; GROWTH-FACTOR; PIOGLITAZONE; ROSIGLITAZONE; FIBROGENESIS; LIPOCYTES; THERAPY;
D O I
10.1016/j.biocel.2010.02.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nonalcoholic steatohepatitis with fibrosis is a more severe form of nonalcoholic fatty liver disease, one of the most common liver diseases We have previously shown that peroxisome proliferator-activated receptors gamma (PPAR gamma) ligand, rosiglitazone, prevented the development of the methionine choline deficient (MCD) diet-induced fibrosing steatohepatitis We have now tested whether overexpression of PPAR gamma ameliorates established steatohepatins and fibrosis Male C57BL6 mice fed with MCD diet for 8 weeks developed hepatic fibrosis with increased hepatic expression of collagen1 alpha(1), inhibitors of fibrosis reversal-1, regulator involved in matrix degradation-9 and connective tissue growth factor After 2 weeks of transduction of PPAR gamma through an adenovirus-expressing PPAR gamma (Ad-PPAR gamma), expression of these genes was reduced in a manner that paralleled the reduction in activated hepatic stellate cells (HSCs) and resolution of liver fibrosis. On the in vitro study. PPAR gamma is expressed in primary quiescent HSC, but depleted in culture activated HSC Conversely, ectopic expression of PPAR gamma in activated HSC achieved the phenotypic reversal to the quiescent cell Such induction markedly suppressed cell viability and cell proliferation, downregulated proliferating cell nuclear antigen, and caused cell cycle arrest at G0/G1 phase. Further, introduction of PPAR gamma in HSC increased cell apoptosis, this was confirmed by enhanced expression of FasL, cleaved caspase-3, cleaved caspase-7 and poly ADP-ribose polymerase, indicating an extrinsic apoptosis pathway. In conclusion, the present study shows that MCD diet-Induced fibrosing steatohepatitis can be reversed by overexpression of PPAR gamma. It is likely that PPAR gamma reverses fibrosis by reducing HSCs proliferation, inducing cell cycle arrest and apoptosis. (C) 2010 Elsevier Ltd All rights reserved
引用
收藏
页码:948 / 957
页数:10
相关论文
共 37 条
  • [1] Antifibrotic agents for liver disease
    Albanis, E
    Friedman, SL
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (01) : 12 - 19
  • [2] Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
    Angulo, P
    Keach, JC
    Batts, KP
    Lindor, KD
    [J]. HEPATOLOGY, 1999, 30 (06) : 1356 - 1362
  • [3] Arthur MJP, 2000, AM J PHYSIOL-GASTR L, V279, pG245
  • [4] Expanding the natural history from cryptogenic cirrhosis to of nonalcoholic steatohepatitis: Hepatocellular carcinoma
    Bugianesi, E
    Leone, N
    Vanni, E
    Marchesini, G
    Brunello, F
    Carucci, P
    Musso, A
    De Paolis, P
    Capussotti, L
    Salizzoni, M
    Rizzetto, M
    [J]. GASTROENTEROLOGY, 2002, 123 (01) : 134 - 140
  • [5] PPARγ agonists inhibit TGF-β induced pulmonary myofibroblast differentiation and collagen production:: implications for therapy of lung fibrosis
    Burgess, HA
    Daugherty, LE
    Thatcher, TH
    Lakatos, HF
    Ray, DM
    Redonnet, M
    Phipps, RP
    Sime, PJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2005, 288 (06) : L1146 - L1153
  • [6] Long-term follow-up of patients with NAFLD and elevated liver enzymes
    Ekstedt, Mattias
    Franzen, Lennart E.
    Mathiesen, Ulrik L.
    Thorelius, Lars
    Holmqvist, Marika
    Bodemar, Goran
    Kechagias, Stergios
    [J]. HEPATOLOGY, 2006, 44 (04) : 865 - 873
  • [7] RETINOL RELEASE BY ACTIVATED RAT HEPATIC LIPOCYTES - REGULATION BY KUPFFER CELL-CONDITIONED MEDIUM AND PDGF
    FRIEDMAN, SL
    WEI, SH
    BLANER, WS
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (05): : G947 - G952
  • [8] FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828
  • [9] Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury
    Friedman, SL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (04) : 2247 - 2250
  • [10] Peroxisome proliferator-activated receptor γ transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells
    Galli, A
    Crabb, D
    Price, D
    Ceni, E
    Salzano, R
    Surrenti, C
    Casini, A
    [J]. HEPATOLOGY, 2000, 31 (01) : 101 - 108